JIAN HUANG
Dentist in Philadelphia, PA
License number
Pennsylvania DS037977
Category
Dentistry
Type
Dentist
Address
Address
Philadelphia, PA 19103
Professional information
Risk Strategy Analyst At Bank Of America
Position:
VP, Risk Stat Analyst III at Bank of America
Location:
Greater Philadelphia Area
Industry:
Banking
Work:
Bank of America
since Aug 2006
-
VP, Risk Stat Analyst III
Education:
Rutgers, The State University of New Jersey-New Brunswick 2002 - 2004
MS, Statistics
MS, Statistics
Jian Huang - Philadelphia, PA
Work:
VOYA Financial
Financial Analysis Drexel University - Philadelphia, PA
School Project The Campaign - Philadelphia, PA
Volunteer Income Tax Assistance Bellevue College Bookstore - Bellevue, WA
Customer Service Hope-Link - Bellevue, WA
Office Assistant
Financial Analysis Drexel University - Philadelphia, PA
School Project The Campaign - Philadelphia, PA
Volunteer Income Tax Assistance Bellevue College Bookstore - Bellevue, WA
Customer Service Hope-Link - Bellevue, WA
Office Assistant
Education:
Drexel University - P
Bachelor of Science in Business Administration Anticipated Graduation - June 2015 in Accounting Drexel University - p
Bachelor of Science in Business Administration Anticipated Graduation - June 2015 in Accounting Drexel University - Philadelphia, PA
Bachelor of Science in Business Administration
Bachelor of Science in Business Administration Anticipated Graduation - June 2015 in Accounting Drexel University - p
Bachelor of Science in Business Administration Anticipated Graduation - June 2015 in Accounting Drexel University - Philadelphia, PA
Bachelor of Science in Business Administration
Skills:
Computer: Proficient in Excel, Word and PowerPoint
In Vivo And Ex Vivo Expansion Of Hematopoietic Stem Cells With A Targeted Combination Of Clinically Tested, Fda Approved Drugs
US Patent:
2011025, Oct 13, 2011
Filed:
Apr 11, 2011
Appl. No.:
13/084180
Inventors:
Peter S. Klein - Wynnewood PA, US
Jian Huang - Philadelphia PA, US
Jian Huang - Philadelphia PA, US
International Classification:
A61M 37/00, A61K 35/28, A61P 35/00, A61P 7/06, A61P 19/08, C12N 5/0775, A61P 35/02
US Classification:
604522, 435375, 435372, 435325, 424 937
Abstract:
The present invention provides a therapeutic approach to maintain and expand HSCs in vivo using currently available medications that target GSK-3 and mTOR. The present invention also provides a system and method for the ex vivo culturing of HSCs, where an mTOR inhibitor is combined with a GSK-3 inhibitor within the culturing conditions.